Rajesh Devraj

2.8k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Rajesh Devraj is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rajesh Devraj has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Rajesh Devraj's work include Synthesis and Characterization of Heterocyclic Compounds (7 papers), Melanoma and MAPK Pathways (7 papers) and Synthesis and biological activity (6 papers). Rajesh Devraj is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (7 papers), Melanoma and MAPK Pathways (7 papers) and Synthesis and biological activity (6 papers). Rajesh Devraj collaborates with scholars based in United States, United Kingdom and Canada. Rajesh Devraj's co-authors include Aleem Gangjee, John J. Parlow, Michael S. South, Robert Hughes, Raul Krauss, Thomas M. Engber, Todd Bosanac, Nigel Greene, Travis T. Wager and Yao Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Brain and Biochemistry.

In The Last Decade

Rajesh Devraj

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiochemical drug properties associated with in vivo toxicological outcomes

2008 675 citations Jason D. Hughes, Julian Blagg et al. Bioorganic & Medicinal Chemistry Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rajesh Devraj United States	20	951	746	382	218	157	35	1.9k
Brian Springthorpe United Kingdom	5	879 0.9×	546 0.7×	589 1.5×	188 0.9×	223 1.4×	8	1.8k
John P. Mallamo United States	29	1.1k 1.1×	1.1k 1.5×	235 0.6×	272 1.2×	51 0.3×	64	2.3k
Toshimasa Tanaka Japan	27	1.3k 1.3×	992 1.3×	327 0.9×	450 2.1×	130 0.8×	59	2.6k
Robin A. E. Carr United Kingdom	16	1.7k 1.8×	624 0.8×	594 1.6×	178 0.8×	87 0.6×	26	2.3k
Martin Rowlands United Kingdom	29	1.5k 1.6×	637 0.9×	252 0.7×	273 1.3×	248 1.6×	67	2.6k
Sonia Lobo Planey United States	15	807 0.8×	297 0.4×	281 0.7×	255 1.2×	91 0.6×	26	1.7k
Paul V. Fish United Kingdom	22	1.9k 2.0×	648 0.9×	286 0.7×	324 1.5×	82 0.5×	59	3.0k
Andreas Link Germany	24	1.4k 1.4×	813 1.1×	136 0.4×	205 0.9×	74 0.5×	121	2.3k
Antonia F. Stepan United States	20	733 0.8×	1.7k 2.2×	308 0.8×	156 0.7×	313 2.0×	37	2.9k
Marinella Roberti Italy	35	1.6k 1.7×	1.5k 2.1×	284 0.7×	459 2.1×	122 0.8×	111	3.6k

Countries citing papers authored by Rajesh Devraj

Since Specialization

Citations

This map shows the geographic impact of Rajesh Devraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Devraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Devraj more than expected).

Fields of papers citing papers by Rajesh Devraj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Devraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Devraj. The network helps show where Rajesh Devraj may publish in the future.

Co-authorship network of co-authors of Rajesh Devraj

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh Devraj. A scholar is included among the top collaborators of Rajesh Devraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh Devraj. Rajesh Devraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hughes, Robert, Todd Bosanac, Xianrong Mao, et al.. (2021). Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate. Cell Reports. 34(1). 108588–108588. 119 indexed citations

Sasaki, Yo, Thomas M. Engber, Robert Hughes, et al.. (2020). cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons. Experimental Neurology. 329. 113252–113252. 73 indexed citations

Krauss, Raul, Todd Bosanac, Rajesh Devraj, Thomas M. Engber, & Robert Hughes. (2020). Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration. Trends in Pharmacological Sciences. 41(4). 281–293. 90 indexed citations

Devadas, Balekudru, Shaun R. Selness, Lei Xing, et al.. (2011). Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(13). 3856–3860. 19 indexed citations

Trujillo, John I., Wei Huang, Robert Hughes, et al.. (2011). Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs. Bioorganic & Medicinal Chemistry Letters. 21(6). 1827–1831. 4 indexed citations

Li, Xing, Balekudru Devadas, Rajesh Devraj, et al.. (2011). Discovery and Characterization of Atropisomer PH‐797804, a p38 MAP Kinase Inhibitor, as a Clinical Drug Candidate. ChemMedChem. 7(2). 273–280. 32 indexed citations

Hepperle, Michael, et al.. (2010). Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 20(10). 3146–3149. 7 indexed citations

Devraj, Rajesh, et al.. (2010). The Art Of Bollywood. Medical Entomology and Zoology. 2 indexed citations

Walker, John K., Shaun R. Selness, Rajesh Devraj, et al.. (2010). Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 20(8). 2634–2638. 19 indexed citations

10.

Hope, Heidi R., Gary D. Anderson, Barry Burnette, et al.. (2009). Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation. Journal of Pharmacology and Experimental Therapeutics. 331(3). 882–895. 46 indexed citations

11.

Hughes, Jason D., Julian Blagg, David A. Price, et al.. (2008). Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorganic & Medicinal Chemistry Letters. 18(17). 4872–4875. 675 indexed citations breakdown →

12.

Parlow, John J., Rajesh Devraj, & Michael S. South. (1999). Solution-phase chemical library synthesis using polymerassisted purification techniques. Current Opinion in Chemical Biology. 3(3). 320–336. 75 indexed citations

13.

HAUGWITZ, R. D., et al.. (1998). ChemInform Abstract: Highly Efficient Diastereoselective Michael Addition of Various Thiols to (+)‐Brefeldin A.. ChemInform. 29(23). 1 indexed citations

14.

Flynn, Daniel L., J. Z. CRICH, Rajesh Devraj, et al.. (1997). Chemical Library Purification Strategies Based on Principles of Complementary Molecular Reactivity and Molecular Recognition. Journal of the American Chemical Society. 119(21). 4874–4881. 169 indexed citations

15.

Cody, Vivian, Nikolai Galitsky, J.R. Luft, et al.. (1997). Comparison of Ternary Complexes ofPneumocystis cariniiand Wild-Type Human Dihydrofolate Reductase with Coenzyme NADPH and a Novel Classical Antitumor Furo[2,3-d]pyrimidine Antifolate. Acta Crystallographica Section D Biological Crystallography. 53(6). 638–649. 27 indexed citations

16.

Devraj, Rajesh, et al.. (1996). Synthesis of a series of cytotoxic 2-acyl-1,2-dihydroellipticines which inhibit topoisomerase II.. PubMed. 11(4). 311–24. 4 indexed citations

17.

Devraj, Rajesh & Mark Cushman. (1996). A Versatile Solid Phase Synthesis of Lavendustin A and Certain Biologically Active Analogs. The Journal of Organic Chemistry. 61(26). 9368–9373. 30 indexed citations

18.

Devraj, Rajesh, John F. Barrett, Jeffrey Fernandez, John A. Katzenellenbogen, & Mark Cushman. (1996). ChemInform Abstract: Design, Synthesis, and Biological Evaluation of Ellipticine‐Estradiol Conjugates.. ChemInform. 27(49). 1 indexed citations

19.

Gangjee, Aleem, Rajesh Devraj, John J. McGuire, & Roy L. Kisliuk. (1995). Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines. Journal of Medicinal Chemistry. 38(19). 3798–3805. 56 indexed citations

20.

Gangjee, Aleem, Rajesh Devraj, John J. McGuire, & Roy L. Kisliuk. (1995). 5-Arylthio Substituted 2-Amino-4-oxo-6-methylpyrrolo[2,3-d]pyrimidine Antifolates as Thymidylate Synthase Inhibitors and Antitumor Agents. Journal of Medicinal Chemistry. 38(22). 4495–4502. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact